9.39
price down icon10.57%   -1.11
after-market Dopo l'orario di chiusura: 9.60 0.21 +2.24%
loading

Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie

pulisher
09:34 AM

Why Did bioAffinity (NASDAQ:BIAF) Regain Nasdaq Compliance? - Kalkine Media

09:34 AM
pulisher
Sep 09, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com

Sep 09, 2026
pulisher
Sep 09, 2026

bioAffinity Technologies shares rise after Nasdaq compliance update - Quiver Quantitative

Sep 09, 2026
pulisher
Sep 09, 2026

BIAF Stock Jumps As Federal Deal Fuels CyPath Lung Momentum - timothysykes.com

Sep 09, 2026
pulisher
Sep 09, 2026

bioAffinity Technologies regains Nasdaq compliance after bid-price recovery - TradingView

Sep 09, 2026
pulisher
Sep 09, 2026

BIAF Stock Pops As CyPath Lung Wins Federal Distribution - StocksToTrade

Sep 09, 2026
pulisher
Sep 09, 2026

Congrats to the folks who joined at $10. Don't forget to give me a like 😘 - Moomoo

Sep 09, 2026
pulisher
Sep 09, 2026

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Yahoo Finance UK

Sep 09, 2026
pulisher
Sep 08, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 08, 2026
pulisher
Sep 08, 2026

Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill

Sep 08, 2026
pulisher
Sep 07, 2026

Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat

Sep 07, 2026
pulisher
Sep 06, 2026

Trending Stocks Today | BioAffinity Technologies Shoots up 56.75% - Moomoo

Sep 06, 2026
pulisher
Sep 05, 2026

Small Cap Stocks To Follow NowSeptember 5th - MarketBeat

Sep 05, 2026
pulisher
Sep 05, 2026

BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - StocksToTrade

Sep 05, 2026
pulisher
Sep 05, 2026

bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance

Sep 05, 2026
pulisher
Sep 04, 2026

AOUT, NX, and BIAF stocks soar on strong earnin... - pluang.com

Sep 04, 2026
pulisher
Sep 04, 2026

bioAffinity Technologies Inc. Warrant (BIAFW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com

Sep 04, 2026
pulisher
Sep 04, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Sep 04, 2026
pulisher
Sep 04, 2026

$15.5 to $19.35 🫡 - Moomoo

Sep 04, 2026
pulisher
Sep 04, 2026

You know I'm drunk, so my words carry extra weight 😘 - Moomoo

Sep 04, 2026
pulisher
Sep 03, 2026

bioAffinity Technologies to Present Corporate Update at Conference - TipRanks

Sep 03, 2026
pulisher
Sep 03, 2026

bioAffinity Technologies to Present Corporate Update at H.C. Wainwright Conference; Market Cap ~$5.9M - TradingView

Sep 03, 2026
pulisher
Sep 03, 2026

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance

Sep 03, 2026
pulisher
Sep 03, 2026

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federa - The National Law Review

Sep 03, 2026
pulisher
Sep 03, 2026

Biotech Stocks To Follow NowSeptember 3rd - MarketBeat

Sep 03, 2026
pulisher
Sep 03, 2026

BIAF Stock Pops As Federal Lung Test Deal Fuels Momentum - timothysykes.com

Sep 03, 2026
pulisher
Sep 03, 2026

BIAF Stock Jumps As Federal Deal Fuels Lung Test Growth - StocksToTrade

Sep 03, 2026
pulisher
Sep 03, 2026

bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update - Yahoo Finance

Sep 03, 2026
pulisher
Sep 03, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com

Sep 03, 2026
pulisher
Sep 03, 2026

BIAF Stock Pops As CyPath Lung Scores Big VA Deal - timothysykes.com

Sep 03, 2026
pulisher
Sep 03, 2026

Why is bioAffinity Technologies stock surging today? By Investing.com - Investing.com Nigeria

Sep 03, 2026
pulisher
Sep 02, 2026

Small Cap Stocks To Watch NowSeptember 2nd - MarketBeat

Sep 02, 2026
pulisher
Sep 02, 2026

bioAffinity Technologies Surges as CyPath Lung Expands Into Cancer Recurrence Monitoring - finance.biggo.com

Sep 02, 2026
pulisher
Sep 02, 2026

BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening? - Benzinga

Sep 02, 2026
pulisher
Sep 01, 2026

bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors - BioSpace

Sep 01, 2026
pulisher
Sep 01, 2026

Get insights into the top gainers and losers of Tuesday's after-hours session. - ChartMill

Sep 01, 2026
pulisher
Sep 01, 2026

bioAffinity Technologies advances CyPath Lung for post-treatment surveillance - TradingView

Sep 01, 2026
pulisher
Sep 01, 2026

Why Is bioAffinity Technologies Stock Trading Higher Today?bioAffinity Technologies (NASDAQ:BIAF) - Benzinga

Sep 01, 2026
pulisher
Sep 01, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - benzinga.com

Sep 01, 2026
pulisher
Sep 01, 2026

Top Biotech Stocks Worth WatchingSeptember 1st - MarketBeat

Sep 01, 2026
pulisher
Sep 01, 2026

bioAffinity Technologies Advances CyPath Lung for Post-Treatment Lung Cancer Surveillance - finance.yahoo.com

Sep 01, 2026
pulisher
Sep 01, 2026

BIAF jumps as bioAffinity highlights expanded CyPath Lung use case - Quiver Quantitative

Sep 01, 2026
pulisher
Sep 01, 2026

bioAffinity shares jump 45% on CyPath news, trading volume rises to 56 times share count - TechStock²

Sep 01, 2026
pulisher
Sep 01, 2026

BIAF Stock Surges On VA Deal And Lung Test Momentum - StocksToTrade

Sep 01, 2026
pulisher
Sep 01, 2026

BIAF Stock Pops As Federal Deal Fuels Volatile Run - timothysykes.com

Sep 01, 2026
pulisher
Sep 01, 2026

$bioAffinity Technologies (BIAF.US)$ sold a tad early.. but managed to kept my greens! - Moomoo

Sep 01, 2026
pulisher
Sep 01, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com

Sep 01, 2026
pulisher
Sep 01, 2026

Catalysts Emerge BIAF, LIDR, SSM, GMGMF to Watch Now - FinancialContent

Sep 01, 2026
pulisher
Aug 24, 2026

bioAffinity (BIAF) Results Review: The EPS Result Is Below Expectation for This Review; Closing Reaction: The Market Price Declines 1.25% at the CloseEstimate Revision Count - vinanet.vn

Aug 24, 2026
pulisher
Aug 24, 2026

bioAffinity Technologies Inc. Warrant (BIAFW) Peer Comparison – Compare with Others - valueresearchonline.com

Aug 24, 2026
pulisher
Aug 21, 2026

Price to earnings forward of bioAffinity Technologies, Inc. – BOATS:BIAFW - TradingView

Aug 21, 2026
pulisher
Aug 20, 2026

bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - BioSpace

Aug 20, 2026
pulisher
Aug 20, 2026

bioAffinity Technologies Implements Reverse Stock Split for Nasdaq - TipRanks

Aug 20, 2026
pulisher
Aug 20, 2026

bioAffinity Technologies Sets 1-for-15 Reverse Stock Split for August 24 - citybiz

Aug 20, 2026
pulisher
Aug 20, 2026

bioAffinity Technologies executes 1-for-15 reverse stock split - Investing.com

Aug 20, 2026
pulisher
Aug 20, 2026

BioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - marketscreener.com

Aug 20, 2026
pulisher
Aug 20, 2026

bioAffinity (BIAF) Earnings Snapshot: The Available Earnings Metric Delivers a Miss in the Reported Period; Trading Move: The Stock Ends Down 13.59% in Latest TradingFinancial Summary - vinanet.vn

Aug 20, 2026
pulisher
Aug 19, 2026

BioAffinity Technologies Announces Closing of - Moomoo

Aug 19, 2026
pulisher
Aug 19, 2026

bioAffinity Technologies expands CyPath Lung federal distribution - The Globe and Mail

Aug 19, 2026
pulisher
Aug 18, 2026

These stocks are the most active in today's session - ChartMill

Aug 18, 2026
pulisher
Aug 18, 2026

bioAffinity Technologies Signs Nationwide Federal Healthcare Distribution Agreement for CyPath Lung - Yahoo Finance

Aug 18, 2026
pulisher
Aug 18, 2026

bioAffinity partners with AvMEDICAL for VA distribution - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

Form 8K bioAffinity Technologies Inc For: 18 August By Investing.com - Investing.com Nigeria

Aug 18, 2026
DGX DGX
$231.14
price down icon 1.83%
MTD MTD
$1,280.58
price down icon 0.76%
$201.27
price down icon 1.82%
WAT WAT
$401.64
price down icon 0.78%
$506.53
price down icon 1.67%
A A
$143.12
price down icon 1.13%
Capitalizzazione:     |  Volume (24 ore):